🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchHas anyone dealt with pemvidutide phase 2? Page 2

Has anyone dealt with pemvidutide phase 2?

greg_boulder Fri, Dec 26, 2025 at 10:30 PM 6 replies 667 viewsPage 2 of 2
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Dec 27, 2025 at 1:20 AM#6
Dr.NateNeph said:
— in my experience this comes down to a few key factors

I respect Dr.NateNeph perspective but I think this oversimplifies things a bit. Re: Has anyone dealt with — the effect size varies considerably by population.

I am not saying Dr.NateNeph wrong entirely — just that the picture is more nuanced than a blanket statement. The SURMOUNT data specifically shows baseline BMI-dependent responses.

17 1FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 14 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Dec 27, 2025 at 1:37 AM#7

Relevant to Has anyone dealt with — here is my latest bloodwork comparison:

Key improvements: A1C 8.0% → 5.3%, triglycerides 195 → 95 mg/dL, hsCRP 6.0 → 1.3 mg/L. All on tirzepatide for 11 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

25 23Dr.PulmRoch, maya_sedona, stefan_berlin and 22 others
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Dec 27, 2025 at 1:54 AM#8

Thank you TrialTracker_MD! This is incredibly helpful. Bookmarking for later. 🙏

Last edited: Dec 27, 2025 at 2:54 AM
15 9robert_kc, dan_philly, MeganSA_TX and 12 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Dec 27, 2025 at 2:11 AM#9

Slightly tangential to Has anyone dealt with but Dr.PulmRoch reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

26 14Dr.LeslieOBGYN, MikeNYC_runner and 23 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 27, 2025 at 2:28 AM#10

Moderator note: Reminder: nothing posted here constitutes medical advice. Consult your healthcare provider.

Tagging this for the weekly digest. 👍

50 16PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 47 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register